{"id":120,"date":"2017-03-29T21:08:54","date_gmt":"2017-03-29T21:08:54","guid":{"rendered":"http:\/\/34.138.3.201\/?page_id=120"},"modified":"2025-07-31T18:28:57","modified_gmt":"2025-07-31T18:28:57","slug":"dr-pedro-rosa-neto","status":"publish","type":"page","link":"https:\/\/mcsa.ca\/index.php\/publications\/dr-pedro-rosa-neto\/","title":{"rendered":"Dr. Pedro Rosa-Neto"},"content":{"rendered":"\n
    \n
  1. Ossenkoppele, R, Coomans, EM, Apostolova, LG, Baker, SL, Barthel, H, Beach, TG et al.<\/em>. Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-\u03b2 status, APOE genotype and sex. Nat Neurosci. 2025; :. doi: 10.1038\/s41593-025-02000-6<\/a>. PubMed PMID:40670684<\/a> .<\/li>\n\n\n\n
  2. Rohden, F, Ferreira, PCL, Bellaver, B, Ferrari-Souza, JP, Aguzzoli, CS, Soares, C et al.<\/em>. Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer’s disease. Nat Commun. 2025;16 (1):5653. doi: 10.1038\/s41467-025-60806-1<\/a>. PubMed PMID:40593718<\/a> PubMed Central PMC12215965<\/a>.<\/li>\n\n\n\n
  3. Moscoso, A, Heeman, F, Raghavan, S, Costoya-S\u00e1nchez, A, van Essen, M, Mainta, I et al.<\/em>. Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity. JAMA. 2025;334 (3):229-242. doi: 10.1001\/jama.2025.7817<\/a>. PubMed PMID:40522652<\/a> .<\/li>\n\n\n\n
  4. Abbas, S, Ferreira, PCL, Bellaver, B, Povala, G, Rohden, F, Aguzzoli, CS et al.<\/em>. Utility of plasma GFAP as a secondary endpoint for clinical trials in Alzheimer’s disease. J Prev Alzheimers Dis. 2025;12 (7):100205. doi: 10.1016\/j.tjpad.2025.100205<\/a>. PubMed PMID:40473528<\/a> .<\/li>\n\n\n\n
  5. Chen, CD, Franklin, EE, Li, Y, Joseph-Mathurin, N, Burns, AL, Hobbs, DA et al.<\/em>. Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease. Acta Neuropathol. 2025;149 (1):57. doi: 10.1007\/s00401-025-02890-7<\/a>. PubMed PMID:40459787<\/a> PubMed Central PMC12133910<\/a>.<\/li>\n\n\n\n
  6. Planche, V, Mansencal, B, Fonov, V, Manjon, JV, Tourdias, T, Bouzigues, A et al.<\/em>. Anatomical progression of genetic frontotemporal lobar degeneration across the lifespan. Brain. 2025; :. doi: 10.1093\/brain\/awaf195<\/a>. PubMed PMID:40424598<\/a> .<\/li>\n\n\n\n
  7. Hosseini, E, Hosseini, SA, Servaes, S, Hall, B, Rosa-Neto, P<\/strong>, Moradi, AR et al.<\/em>. Transforming 3D MRI to 2D Feature Maps Using Pre-Trained Models for Diagnosis of Attention Deficit Hyperactivity Disorder. Tomography. 2025;11 (5):. doi: 10.3390\/tomography11050056<\/a>. PubMed PMID:40423258<\/a> PubMed Central PMC12115681<\/a>.<\/li>\n\n\n\n
  8. Bellaver, B, Povala, G, Ferreira, PCL, Bauer-Negrini, G, Lussier, FZ, Leffa, DT et al.<\/em>. Plasma GFAP for populational enrichment of clinical trials in preclinical Alzheimer’s disease. Alzheimers Dement. 2025;21 (5):e70209. doi: 10.1002\/alz.70209<\/a>. PubMed PMID:40346617<\/a> PubMed Central PMC12064411<\/a>.<\/li>\n\n\n\n
  9. Gauthier, S<\/strong>, Therriault, J, Rosa-Neto, P<\/strong>. Cholinergic therapy in Alzheimer disease. Handb Clin Neurol. 2025;211 :155-159. doi: 10.1016\/B978-0-443-19088-9.00015-9<\/a>. PubMed PMID:40340059<\/a> .<\/li>\n\n\n\n
  10. Weiner, S, Sauer, M, Montoliu-Gaya, L, Benedet, AL, Ashton, NJ, Gonzalez-Ortiz, F et al.<\/em>. Cerebrospinal fluid proteome profiling across the Alzheimer’s disease continuum: a step towards solving the equation for ‘X’. Mol Neurodegener. 2025;20 (1):52. doi: 10.1186\/s13024-025-00841-0<\/a>. PubMed PMID:40329321<\/a> PubMed Central PMC12057231<\/a>.<\/li>\n\n\n\n
  11. Pola, I, Ashton, NJ, Ant\u00f4nio De Bastiani, M, Brum, WS, Rahmouni, N, Tan, K et al.<\/em>. Exploring inflammation-related protein expression and its relationship with TSPO PET in Alzheimer’s disease. Alzheimers Dement. 2025;21 (4):e70171. doi: 10.1002\/alz.70171<\/a>. PubMed PMID:40289873<\/a> PubMed Central PMC12035552<\/a>.<\/li>\n\n\n\n
  12. Bezgin, G, Pascoal, TA, Therriault, J, Lussier, FZ, Servaes, S, Kang, MS et al.<\/em>. Tau profiling across Alzheimer’s disease staging reveals vulnerability to disease pathophysiology. Eur J Nucl Med Mol Imaging. 2025; :. doi: 10.1007\/s00259-025-07257-4<\/a>. PubMed PMID:40274672<\/a> .<\/li>\n\n\n\n
  13. Borelli, WV, Ferreira, PCL, Brum, WS, Ferrari-Souza, JP, Carello-Collar, G, Holz, M et al.<\/em>. Diagnostic performance of Alzheimer’s disease blood biomarkers in a Brazilian cohort. medRxiv. 2025; :. doi: 10.1101\/2025.02.23.24319116<\/a>. PubMed PMID:40271009<\/a> PubMed Central PMC12016014<\/a>.<\/li>\n\n\n\n
  14. Mirza, SS, Pasternak, M, Paterson, AD, Rogaeva, E, Tartaglia, MC, Mitchell, SB et al.<\/em>. Disease-modifying effects of TMEM106B in genetic frontotemporal dementia: a longitudinal GENFI study. Brain. 2025; :. doi: 10.1093\/brain\/awaf019<\/a>. PubMed PMID:40260680<\/a> .<\/li>\n\n\n\n
  15. Lantero-Rodriguez, J, Montoliu-Gaya, L, Benedet, AL, Vrillon, A, Dumurgier, J, Cognat, E et al.<\/em>. Correction: CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease. Acta Neuropathol. 2025;149 (1):34. doi: 10.1007\/s00401-025-02877-4<\/a>. PubMed PMID:40257474<\/a> PubMed Central PMC12011925<\/a>.<\/li>\n\n\n\n
  16. Iturria-Medina, Y, Poole, VN, Zammit, AR, Yu, L, Tasaki, S, Hong, JH et al.<\/em>. Translating the Post-Mortem Brain Multi-Omics Molecular Taxonomy of Alzheimer’s Dementia to Living Humans. bioRxiv. 2025; :. doi: 10.1101\/2025.03.20.644323<\/a>. PubMed PMID:40196602<\/a> PubMed Central PMC11974700<\/a>.<\/li>\n\n\n\n
  17. Leffa, D, Povala, G, Ferreira, P, Ferrari-Souza, JP, Bauer-Negrini, G, Rodrigues, M et al.<\/em>. In vivo-measured Lewy body pathology is associated with neuropsychiatric symptoms across the Alzheimer’s disease continuum. Res Sq. 2025; :. doi: 10.21203\/rs.3.rs-6270682\/v1<\/a>. PubMed PMID:40196010<\/a> PubMed Central PMC11975041<\/a>.<\/li>\n\n\n\n
  18. Aliaga, A, Therriault, J, Quispialaya, K, Aliaga, A, Kunach, P, Macedo, AC et al.<\/em>. Autoradiographic comparison between [11<\/sup>C]PiB and [18<\/sup>F]AZD4694 in human brain tissue. EJNMMI Res. 2025;15 (1):30. doi: 10.1186\/s13550-025-01216-8<\/a>. PubMed PMID:40167827<\/a> PubMed Central PMC11961831<\/a>.<\/li>\n\n\n\n
  19. Ossenkoppele, R, Salvad\u00f3, G, Janelidze, S, Pichet Binette, A, Bali, D, Karlsson, L et al.<\/em>. Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials. Nat Aging. 2025;5 (5):883-896. doi: 10.1038\/s43587-025-00835-z<\/a>. PubMed PMID:40155777<\/a> PubMed Central PMC12092243<\/a>.<\/li>\n\n\n\n
  20. Bateman, RJ, Li, Y, McDade, EM, Llibre-Guerra, JJ, Clifford, DB, Atri, A et al.<\/em>. Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer’s disease: an open-label extension of the phase 2\/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial. Lancet Neurol. 2025;24 (4):316-330. doi: 10.1016\/S1474-4422(25)00024-9<\/a>. PubMed PMID:40120616<\/a> PubMed Central PMC12042767<\/a>.<\/li>\n\n\n\n
  21. Lantero-Rodriguez, J, Montoliu-Gaya, L, Ashton, NJ, Pola, I, Therriault, J, Rahmouni, N et al.<\/em>. Biofluid-based staging of Alzheimer’s disease. Acta Neuropathol. 2025;149 (1):27. doi: 10.1007\/s00401-025-02863-w<\/a>. PubMed PMID:40095069<\/a>PubMed Central PMC11913990<\/a>.<\/li>\n\n\n\n
  22. Tremblay, C, Rahayel, S, Pastor-Bernier, A, St-Onge, F, Vo, A, Rheault, F et al.<\/em>. Uncovering atrophy progression pattern and mechanisms in individuals at risk of Alzheimer’s disease. Brain Commun. 2025;7 (2):fcaf099. doi: 10.1093\/braincomms\/fcaf099<\/a>. PubMed PMID:40092368<\/a> PubMed Central PMC11906971<\/a>.<\/li>\n\n\n\n
  23. Hosseini, SA, Hajianfar, G, Hall, B, Servaes, S, Rosa-Neto, P<\/strong>, Ghafarian, P et al.<\/em>. Robust vs. Non-robust radiomic features: the quest for optimal machine learning models using phantom and clinical studies. Cancer Imaging. 2025;25 (1):33. doi: 10.1186\/s40644-025-00857-1<\/a>. PubMed PMID:40075547<\/a> PubMed Central PMC11905451<\/a>.<\/li>\n\n\n\n
  24. Alpaugh, M, Lantero-Rodriguez, J, Benedet, AL, Manseau, U, Boutin, M, Maiuri, M et al.<\/em>. Tau levels in platelets isolated from Huntington’s disease patients serve as a biomarker of disease severity. J Neurol. 2025;272 (3):254. doi: 10.1007\/s00415-025-12966-9<\/a>. PubMed PMID:40047995<\/a> PubMed Central PMC11885373<\/a>.<\/li>\n\n\n\n
  25. Yakoub, Y, Gonzalez-Ortiz, F, Ashton, NJ, D\u00e9ry, C, Strikwerda-Brown, C, St-Onge, F et al.<\/em>. Plasma p-tau217 identifies cognitively normal older adults who will develop cognitive impairment in a 10-year window. Alzheimers Dement. 2025;21 (2):e14537. doi: 10.1002\/alz.14537<\/a>. PubMed PMID:40008832<\/a> PubMed Central PMC11863240<\/a>.<\/li>\n\n\n\n
  26. Leffa, DT, Povala, G, Bellaver, B, Ferrari-Souza, JP, Ferreira, PCL, Lussier, FZ et al.<\/em>. Impact of the polygenic risk scores for attention-deficit\/hyperactivity disorder in Alzheimer’s disease. Alzheimers Dement. 2025;21 (2):e70003. doi: 10.1002\/alz.70003<\/a>. PubMed PMID:39998851<\/a> PubMed Central PMC11853731<\/a>.<\/li>\n\n\n\n
  27. Milella, MS, Minuzzi, L, Benkelfat, C, Soucy, JP, Kirlow, A, Schirrmacher, E et al.<\/em>. Quantification of [11<\/sup>C]ABP688 Binding to mGluR5 in Human Brain using Cerebellum as Reference Region: Biological Interpretation and Limitations. Curr Neuropharmacol. 2025;23 (9):1081-1094. doi: 10.2174\/1570159X23666250127161855<\/a>. PubMed PMID:39976038<\/a> PubMed Central PMC12272086<\/a>.<\/li>\n\n\n\n
  28. Bateman, RJ, Li, Y, McDade, EM, Llibre-Guerra, JJ, Clifford, DB, Atri, A et al.<\/em>. Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer’s disease: an open label extension of the phase 2\/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial. medRxiv. 2025; :. doi: 10.1101\/2024.10.29.24316289<\/a>. PubMed PMID:39974075<\/a> PubMed Central PMC11838922<\/a>.<\/li>\n\n\n\n
  29. Arslan, B, Brum, WS, Pola, I, Therriault, J, Rahmouni, N, Stevenson, J et al.<\/em>. The impact of kidney function on Alzheimer’s disease blood biomarkers: implications for predicting amyloid-\u03b2 positivity. Alzheimers Res Ther. 2025;17 (1):48. doi: 10.1186\/s13195-025-01692-z<\/a>. PubMed PMID:39972340<\/a> PubMed Central PMC11837363<\/a>.<\/li>\n\n\n\n
  30. Yun, J, Shin, D, Lee, EH, Kim, JP, Ham, H, Gu, Y et al.<\/em>. Temporal Dynamics and Biological Variability of Alzheimer Biomarkers. JAMA Neurol. 2025;82 (4):384-96. doi: 10.1001\/jamaneurol.2024.5263<\/a>. PubMed PMID:39960728<\/a> PubMed Central PMC11833660<\/a>.<\/li>\n\n\n\n
  31. Islam, T, Hill, E, Abrahamson, EE, Servaes, S, Smirnov, DS, Zeng, X et al.<\/em>. Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer’s disease. Nat Med. 2025;31 (2):574-588. doi: 10.1038\/s41591-024-03400-0<\/a>. PubMed PMID:39930142<\/a> PubMed Central PMC11835754<\/a>.<\/li>\n\n\n\n
  32. Llibre-Guerra, JJ, Fernandez, MV, Joseph-Mathurin, N, Bian, S, Carter, K, Li, Y et al.<\/em>. Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementia. Nat Med. 2025;31 (4):1267-1275. doi: 10.1038\/s41591-025-03494-0<\/a>. PubMed PMID:39930140<\/a> PubMed Central PMC12024232<\/a>.<\/li>\n\n\n\n
  33. Sogorb-Esteve, A, Weiner, S, Simr\u00e9n, J, Swift, IJ, Bocchetta, M, Todd, EG et al.<\/em>. Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes. Sci Transl Med. 2025;17 (784):eadm9654. doi: 10.1126\/scitranslmed.adm9654<\/a>. PubMed PMID:39908349<\/a> .<\/li>\n\n\n\n
  34. Liu, H, Marsh, TW, Shi, X, Renton, AE, Bowling, KM, Ziegemeier, E et al.<\/em>. The landscape of autosomal-dominant Alzheimer’s disease: global distribution and age of onset. Brain. 2025;148 (7):2429-2440. doi: 10.1093\/brain\/awaf038<\/a>. PubMed PMID:39903689<\/a> PubMed Central PMC12233549<\/a>.<\/li>\n\n\n\n
  35. Smith, EE, Phillips, NA, Feldman, HH, Borrie, M, Ganesh, A, Henri-Bhargava, A et al.<\/em>. Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research. J Prev Alzheimers Dis. 2025;12 (3):100068. doi: 10.1016\/j.tjpad.2025.100068<\/a>. PubMed PMID:39893139<\/a> PubMed Central PMC12184013<\/a>.<\/li>\n\n\n\n
  36. Da Ros, LU, Borelli, WV, Aguzzoli, CS, De Bastiani, MA, Schilling, LP, Santamaria-Garcia, H et al.<\/em>. Social and health disparities associated with healthy brain ageing in Brazil and in other Latin American countries. Lancet Glob Health. 2025;13 (2):e277-e284. doi: 10.1016\/S2214-109X(24)00451-0<\/a>. PubMed PMID:39890228<\/a> PubMed Central PMC12035733<\/a>.<\/li>\n\n\n\n
  37. Fern\u00e1ndez Arias, J, Brum, WS, Salvad\u00f3, G, Therriault, J, Servaes, S, Wang, YT et al.<\/em>. Plasma phosphorylated tau217 strongly associates with memory deficits in the Alzheimer’s disease spectrum. Brain. 2025;148 (7):2384-2399. doi: 10.1093\/brain\/awaf033<\/a>. PubMed PMID:39879633<\/a> .<\/li>\n\n\n\n
  38. Wang, YT, Ashton, NJ, Therriault, J, Benedet, AL, Macedo, AC, Pola, I et al.<\/em>. Identify biological Alzheimer’s disease using a novel nucleic acid-linked protein immunoassay. Brain Commun. 2025;7 (1):fcaf004. doi: 10.1093\/braincomms\/fcaf004<\/a>. PubMed PMID:39845736<\/a> PubMed Central PMC11753389<\/a>.<\/li>\n\n\n\n
  39. Hosseini, SA, Servaes, S, Hall, B, Bhaduri, S, Rajan, A, Rosa-Neto, P<\/strong> et al.<\/em>. Quantitative Physiologic MRI Combined with Feature Engineering for Developing Machine Learning-Based Prediction Models to Distinguish Glioblastomas from Single Brain Metastases. Diagnostics (Basel). 2024;15 (1):. doi: 10.3390\/diagnostics15010038<\/a>. PubMed PMID:39795566<\/a> PubMed Central PMC11720653<\/a>.<\/li>\n\n\n\n
  40. Quispialaya, KM, Therriault, J, Aliaga, A, Benedet, AL, Ashton, NJ, Karikari, T et al.<\/em>. Comparison of Plasma p-tau217 and [18<\/sup>F]FDG-PET for Identifying Alzheimer Disease in People With Early-Onset or Atypical Dementia. Neurology. 2025;104 (2):e210211. doi: 10.1212\/WNL.0000000000210211<\/a>. PubMed PMID:39715476<\/a> PubMed Central PMC11666273<\/a>.<\/li>\n\n\n\n
  41. Chertkow, H, Phillips, N, Rockwood, K, Anderson, N, Andrew, MK, Bartha, R et al.<\/em>. Impact of a national dementia research consortium: The Canadian Consortium on Neurodegeneration in Aging (CCNA). J Alzheimers Dis. 2024;102 (3):535-561. doi: 10.1177\/13872877241290990<\/a>. PubMed PMID:39636028<\/a> .<\/li>\n\n\n\n
  42. Aumont, E, Bedard, MA, Bussy, A, Arias, JF, Tissot, C, Hall, BJ et al.<\/em>. Hippocampal atrophy over two years in relation to tau, amyloid-\u03b2 and memory in older adults. Neurobiol Aging. 2025;146 :48-57. doi: 10.1016\/j.neurobiolaging.2024.11.007<\/a>. PubMed PMID:39631245<\/a> .<\/li>\n\n\n\n
  43. Hofmann, A, H\u00e4sler, LM, Lambert, M, Kaeser, SA, Gr\u00e4ber-Sultan, S, Oberm\u00fcller, U et al.<\/em>. Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer’s disease. Nat Commun. 2024;15 (1):9982. doi: 10.1038\/s41467-024-52937-8<\/a>. PubMed PMID:39557867<\/a> PubMed Central PMC11574007<\/a>.<\/li>\n\n\n\n
  44. Therriault, J, Janelidze, S, Benedet, AL, Ashton, NJ, Arranz Mart\u00ednez, J, Gonzalez-Escalante, A et al.<\/em>. Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability. Nat Aging. 2024;4 (11):1529-1537. doi: 10.1038\/s43587-024-00731-y<\/a>. PubMed PMID:39533113<\/a> PubMed Central PMC11564087<\/a>.<\/li>\n\n\n\n
  45. Woo, MS, Therriault, J, Jonaitis, EM, Wilson, R, Langhough, RE, Rahmouni, N et al.<\/em>. Identification of late-stage tau accumulation using plasma phospho-tau217. EBioMedicine. 2024;109 :105413. doi: 10.1016\/j.ebiom.2024.105413<\/a>. PubMed PMID:39500009<\/a> PubMed Central PMC11570195<\/a>.<\/li>\n\n\n\n
  46. Duchesne, S, Collins, DL, Barlow, L, Bartha, R, Black, S, Chertkow, H et al.<\/em>. Recommendations on Imaging in the Context of Alzheimer’s Disease-Modifying Therapies from the CCNA Imaging Workgroup. Can J Neurol Sci. 2024; :1-9. doi: 10.1017\/cjn.2024.338<\/a>. PubMed PMID:39494933<\/a> .<\/li>\n\n\n\n
  47. Aliaga, A, Therriault, J, Quispialaya, KM, Aliaga, A, Hopewell, R, Rahmouni, N et al.<\/em>. Comparison Between Brain and Cerebellar Autoradiography Using [18<\/sup>F]Flortaucipir, [18<\/sup>F]MK6240, and [18<\/sup>F]PI2620 in Postmortem Human Brain Tissue. J Nucl Med. 2025;66 (1):123-129. doi: 10.2967\/jnumed.124.267539<\/a>. PubMed PMID:39477493<\/a> .<\/li>\n\n\n\n
  48. Quispialaya, KM, Therriault, J, Aliaga, A, Tissot, C, Servaes, S, Rahmouni, N et al.<\/em>. Plasma phosphorylated tau181 outperforms [18<\/sup>F] fluorodeoxyglucose positron emission tomography in the identification of early Alzheimer disease. Eur J Neurol. 2024;31 (12):e16255. doi: 10.1111\/ene.16255<\/a>. PubMed PMID:39447157<\/a> PubMed Central PMC11555153<\/a>.<\/li>\n\n\n\n
  49. Pascoal, TA, Aguzzoli, CS, Lussier, FZ, Crivelli, L, Suemoto, CK, Fortea, J et al.<\/em>. Insights into the use of biomarkers in clinical trials in Alzheimer’s disease. EBioMedicine. 2024;108 :105322. doi: 10.1016\/j.ebiom.2024.105322<\/a>. PubMed PMID:39366844<\/a> PubMed Central PMC11663755<\/a>.<\/li>\n\n\n\n
  50. Kunach, P, Vaquer-Alicea, J, Smith, MS, Monistrol, J, Hopewell, R, Moquin, L et al.<\/em>. Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240. Nat Commun. 2024;15 (1):8497. doi: 10.1038\/s41467-024-52265-x<\/a>. PubMed PMID:39353896<\/a> PubMed Central PMC11445244<\/a>.<\/li>\n\n\n\n
  51. Shen, Y, Timsina, J, Heo, G, Beric, A, Ali, M, Wang, C et al.<\/em>. CSF proteomics identifies early changes in autosomal dominant Alzheimer’s disease. Cell. 2024;187 (22):6309-6326.e15. doi: 10.1016\/j.cell.2024.08.049<\/a>. PubMed PMID:39332414<\/a>PubMed Central PMC11531390<\/a>.<\/li>\n\n\n\n
  52. Macedo, AC, Therriault, J, Tissot, C, Aumont, \u00c9, Servaes, S, Rahmouni, N et al.<\/em>. Modeling the progression of neuropsychiatric symptoms in Alzheimer’s disease with PET-based Braak staging. Neurobiol Aging. 2024;144 :127-137. doi: 10.1016\/j.neurobiolaging.2024.09.009<\/a>. PubMed PMID:39326302<\/a> .<\/li>\n\n\n\n
  53. Wiesman, AI, Madge, V, Fon, EA, Dagher, A, Collins, DL, Baillet, S et al.<\/em>. Associations between neuromelanin depletion and cortical rhythmic activity in Parkinson’s disease. Brain. 2025;148 (3):875-885. doi: 10.1093\/brain\/awae295<\/a>. PubMed PMID:39282945<\/a> PubMed Central PMC11884654<\/a>.<\/li>\n\n\n\n
  54. Hosseini, SA, Hajianfar, G, Ghaffarian, P, Seyfi, M, Hosseini, E, Aval, AH et al.<\/em>. PET radiomics-based lymphovascular invasion prediction in lung cancer using multiple segmentation and multi-machine learning algorithms. Phys Eng Sci Med. 2024;47 (4):1613-1625. doi: 10.1007\/s13246-024-01475-0<\/a>. PubMed PMID:39225775<\/a> PubMed Central PMC11666702<\/a>.<\/li>\n\n\n\n
  55. Pascoal, T, Rohden, F, Ferreira, P, Bellaver, B, Ferrari-Souza, JP, Aguzzoli, C et al.<\/em>. Glial reactivity is linked to synaptic dysfunction across the aging and Alzheimer’s disease spectrum. Res Sq. 2024; :. doi: 10.21203\/rs.3.rs-4782732\/v1<\/a>. PubMed PMID:39184102<\/a> PubMed Central PMC11343173<\/a>.<\/li>\n\n\n\n
  56. Bieger, A, Brum, WS, Borelli, WV, Therriault, J, De Bastiani, MA, Moreira, AG et al.<\/em>. Influence of Different Diagnostic Criteria on Alzheimer Disease Clinical Research. Neurology. 2024;103 (5):e209753. doi: 10.1212\/WNL.0000000000209753<\/a>. PubMed PMID:39167736<\/a> PubMed Central PMC11338500<\/a>.<\/li>\n\n\n\n
  57. Daniels, AJ, McDade, E, Llibre-Guerra, JJ, Xiong, C, Perrin, RJ, Ibanez, L et al.<\/em>. 15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIAN. medRxiv. 2024; :. doi: 10.1101\/2024.08.08.24311689<\/a>. PubMed PMID:39148846<\/a> PubMed Central PMC11326320<\/a>.<\/li>\n\n\n\n
  58. Povala, G, De Bastiani, MA, Bellaver, B, Ferreira, PCL, Ferrari-Souza, JP, Lussier, FZ et al.<\/em>. Omics-derived biological modules reflect metabolic brain changes in Alzheimer’s disease. Alzheimers Dement. 2024;20 (10):6709-6721. doi: 10.1002\/alz.14095<\/a>. PubMed PMID:39140361<\/a> PubMed Central PMC11485394<\/a>.<\/li>\n\n\n\n
  59. Serpente, M, Fenoglio, C, Arcaro, M, Carandini, T, Sacchi, L, Pintus, M et al.<\/em>. Long Non-Coding RNA Profile in Genetic Symptomatic and Presymptomatic Frontotemporal Dementia: A GENFI Study. J Alzheimers Dis. 2024;100 (s1):S187-S196. doi: 10.3233\/JAD-240557<\/a>. PubMed PMID:39121124<\/a> PubMed Central PMC11380264<\/a>.<\/li>\n\n\n\n
  60. Schultz, SA, Liu, L, Schultz, AP, Fitzpatrick, CD, Levin, R, Bellier, JP et al.<\/em>. \u03b3-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer’s disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS). Lancet Neurol. 2024;23 (9):913-924. doi: 10.1016\/S1474-4422(24)00236-9<\/a>. PubMed PMID:39074479<\/a> PubMed Central PMC11822357<\/a>.<\/li>\n\n\n\n
  61. Leuzy, A, Raket, LL, Villemagne, VL, Klein, G, Tonietto, M, Olafson, E et al.<\/em>. Harmonizing tau positron emission tomography in Alzheimer’s disease: The CenTauR scale and the joint propagation model. Alzheimers Dement. 2024;20 (9):5833-5848. doi: 10.1002\/alz.13908<\/a>. PubMed PMID:39041435<\/a> PubMed Central PMC11497758<\/a>.<\/li>\n\n\n\n
  62. Wang, YT, Therriault, J, Tissot, C, Servaes, S, Rahmouni, N, Macedo, AC et al.<\/em>. Hormone therapy is associated with lower Alzheimer’s disease tau biomarkers in post-menopausal females -evidence from two independent cohorts. Alzheimers Res Ther. 2024;16 (1):162. doi: 10.1186\/s13195-024-01509-5<\/a>. PubMed PMID:39034389<\/a> PubMed Central PMC11265084<\/a>.<\/li>\n\n\n\n
  63. Premi, E, Diano, M, Mattioli, I, Altomare, D, Cantoni, V, Bocchetta, M et al.<\/em>. Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study. Brain Commun. 2024;6 (4):fcae185. doi: 10.1093\/braincomms\/fcae185<\/a>. PubMed PMID:39015769<\/a> PubMed Central PMC11249959<\/a>.<\/li>\n\n\n\n
  64. Sanchez-Rodriguez, LM, Khan, AF, Adewale, Q, Bezgin, G, Therriault, J, Fernandez-Arias, J et al.<\/em>. In-vivo neuronal dysfunction by A\u03b2 and tau overlaps with brain-wide inflammatory mechanisms in Alzheimer’s disease. Front Aging Neurosci. 2024;16 :1383163. doi: 10.3389\/fnagi.2024.1383163<\/a>. PubMed PMID:38966801<\/a> PubMed Central PMC11223503<\/a>.<\/li>\n\n\n\n
  65. Ossenkoppele, R, Salvad\u00f3, G, Janelidze, S, Binette, AP, Bali, D, Karlsson, L et al.<\/em>. Prediction of future cognitive decline among cognitively unimpaired individuals using measures of soluble phosphorylated tau or tau tangle pathology. medRxiv. 2024; :. doi: 10.1101\/2024.06.12.24308824<\/a>. PubMed PMID:38947004<\/a> PubMed Central PMC11213114<\/a>.<\/li>\n\n\n\n
  66. Poirier, A, Picard, C, Labont\u00e9, A, Aubry, I, Auld, D, Zetterberg, H et al.<\/em>. PTPRS is a novel marker for early Tau pathology and synaptic integrity in Alzheimer’s disease. Sci Rep. 2024;14 (1):14718. doi: 10.1038\/s41598-024-65104-2<\/a>. PubMed PMID:38926456<\/a> PubMed Central PMC11208446<\/a>.<\/li>\n\n\n\n
  67. da Silva Castanheira, J, Wiesman, AI, Hansen, JY, Misic, B, Baillet, S, PREVENT-AD Research Group et al.<\/em>. The neurophysiological brain-fingerprint of Parkinson’s disease. EBioMedicine. 2024;105 :105201. doi: 10.1016\/j.ebiom.2024.105201<\/a>. PubMed PMID:38908100<\/a> PubMed Central PMC11253223<\/a>.<\/li>\n\n\n\n
  68. Ottoy, J, Kang, MS, Tan, JXM, Boone, L, Vos de Wael, R, Park, BY et al.<\/em>. Tau follows principal axes of functional and structural brain organization in Alzheimer’s disease. Nat Commun. 2024;15 (1):5031. doi: 10.1038\/s41467-024-49300-2<\/a>. PubMed PMID:38866759<\/a> PubMed Central PMC11169286<\/a>.<\/li>\n\n\n\n
  69. Wearn, A, Tremblay, SA, Tardif, CL, Leppert, IR, Gauthier, CJ, Baracchini, G et al.<\/em>. Neuromodulatory subcortical nucleus integrity is associated with white matter microstructure, tauopathy and APOE status. Nat Commun. 2024;15 (1):4706. doi: 10.1038\/s41467-024-48490-z<\/a>. PubMed PMID:38830849<\/a> PubMed Central PMC11148077<\/a>.<\/li>\n\n\n\n
  70. Wang, YT, Ashton, NJ, Servaes, S, Nilsson, J, Woo, MS, Pascoal, TA et al.<\/em>. The relation of synaptic biomarkers with A\u03b2, tau, glial activation, and neurodegeneration in Alzheimer’s disease. Transl Neurodegener. 2024;13 (1):27. doi: 10.1186\/s40035-024-00420-1<\/a>. PubMed PMID:38802928<\/a> PubMed Central PMC11131272<\/a>.<\/li>\n\n\n\n
  71. Yakoub, Y, Gonzalez-Ortiz, F, Ashton, NJ, D\u00e9ry, C, Strikwerda-Brown, C, St-Onge, F et al.<\/em>. Plasma p-tau217 predicts cognitive impairments up to ten years before onset in normal older adults. medRxiv. 2024; :. doi: 10.1101\/2024.05.09.24307120<\/a>. PubMed PMID:38766113<\/a> PubMed Central PMC11100946<\/a>.<\/li>\n\n\n\n
  72. Sanchez-Rodriguez, LM, Bezgin, G, Carbonell, F, Therriault, J, Fernandez-Arias, J, Servaes, S et al.<\/em>. Personalized whole-brain neural mass models reveal combined A\u03b2 and tau hyperexcitable influences in Alzheimer’s disease. Commun Biol. 2024;7 (1):528. doi: 10.1038\/s42003-024-06217-2<\/a>. PubMed PMID:38704445<\/a> PubMed Central PMC11069569<\/a>.<\/li>\n\n\n\n
  73. Kroll, T, Miranda, A, Drechsel, A, Beer, S, Lang, M, Drzezga, A et al.<\/em>. Dynamic neuroreceptor positron emission tomography in non-anesthetized rats using point source based motion correction: A feasibility study with [11<\/sup>C]ABP688. J Cereb Blood Flow Metab. 2024;44 (10):1852-1866. doi: 10.1177\/0271678X241239133<\/a>. PubMed PMID:38684219<\/a>PubMed Central PMC11504418<\/a>.<\/li>\n\n\n\n
  74. Wagemann, O, Liu, H, Wang, G, Shi, X, Bittner, T, Scelsi, MA et al.<\/em>. Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial. JAMA Neurol. 2024;81 (6):582-593. doi: 10.1001\/jamaneurol.2024.0991<\/a>. PubMed PMID:38683602<\/a> PubMed Central PMC11059071<\/a>.<\/li>\n\n\n\n
  75. Butler, T, Wang, X, Chiang, G, Xi, K, Niogi, S, Glodzik, L et al.<\/em>. Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer’s Disease. J Alzheimers Dis. 2024;99 (1):307-319. doi: 10.3233\/JAD-231312<\/a>. PubMed PMID:38669537<\/a> PubMed Central PMC11091576<\/a>.<\/li>\n\n\n\n
  76. Wisch, JK, McKay, NS, Boerwinkle, AH, Kennedy, J, Flores, S, Handen, BL et al.<\/em>. Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer’s disease: a cross-sectional study. Lancet Neurol. 2024;23 (5):500-510. doi: 10.1016\/S1474-4422(24)00084-X<\/a>. PubMed PMID:38631766<\/a> PubMed Central PMC11209765<\/a>.<\/li>\n\n\n\n
  77. Walker, CS, Li, L, Baracchini, G, Tremblay-Mercier, J, Spreng, RN, PREVENT-AD Research Group et al.<\/em>. Neurobehavioral Mechanisms Influencing the Association Between Generativity, the Desire to Promote Well-Being of Younger Generations, and Purpose in Life in Older Adults at Risk for Alzheimer’s Disease. J Gerontol B Psychol Sci Soc Sci. 2024;79 (6):. doi: 10.1093\/geronb\/gbae060<\/a>. PubMed PMID:38623965<\/a> PubMed Central PMC11138215<\/a>.<\/li>\n\n\n\n
  78. Pasternak, M, Mirza, SS, Luciw, N, Mutsaerts, HJMM, Petr, J, Thomas, D et al.<\/em>. [Not Available]. Alzheimers Dement. 2024;20 (5):3525-3542. doi: 10.1002\/alz.13750<\/a>. PubMed PMID:38623902<\/a> PubMed Central PMC11095434<\/a>.<\/li>\n\n\n\n
  79. Samra, K, Peakman, G, MacDougall, AM, Bouzigues, A, Greaves, CV, Convery, RS et al.<\/em>. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia. Alzheimers Dement (Amst). 2024;16 (2):e12571. doi: 10.1002\/dad2.12571<\/a>. PubMed PMID:38623386<\/a> PubMed Central PMC11016817<\/a>.<\/li>\n\n\n\n
  80. Dauar, MT, Picard, C, Labont\u00e9, A, Breitner, J, Rosa-Neto, P<\/strong>, Villeneuve, S et al.<\/em>. Contactin 5 and Apolipoproteins Interplay in Alzheimer’s Disease. J Alzheimers Dis. 2024;98 (4):1361-1375. doi: 10.3233\/JAD-231003<\/a>. PubMed PMID:38578887<\/a> .<\/li>\n\n\n\n
  81. Hosseini, SA, Shiri, I, Ghaffarian, P, Hajianfar, G, Avval, AH, Seyfi, M et al.<\/em>. The effect of harmonization on the variability of PET radiomic features extracted using various segmentation methods. Ann Nucl Med. 2024;38 (7):493-507. doi: 10.1007\/s12149-024-01923-7<\/a>. PubMed PMID:38575814<\/a> PubMed Central PMC11217131<\/a>.<\/li>\n\n\n\n
  82. Doering, S, McCullough, A, Gordon, BA, Chen, CD, McKay, N, Hobbs, D et al.<\/em>. Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging. EBioMedicine. 2024;103 :105080. doi: 10.1016\/j.ebiom.2024.105080<\/a>. PubMed PMID:38552342<\/a> PubMed Central PMC10995809<\/a>.<\/li>\n\n\n\n
  83. Baril, AA, Picard, C, Labont\u00e9, A, Sanchez, E, Duclos, C, Mohammediyan, B et al.<\/em>. Longer sleep duration and neuroinflammation in at-risk elderly with a parental history of Alzheimer’s disease. Sleep. 2024;47 (6):. doi: 10.1093\/sleep\/zsae081<\/a>. PubMed PMID:38526098<\/a> PubMed Central PMC11168764<\/a>.<\/li>\n\n\n\n
  84. Brum, WS, Cullen, NC, Therriault, J, Janelidze, S, Rahmouni, N, Stevenson, J et al.<\/em>. A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings. Nat Commun. 2024;15 (1):2311. doi: 10.1038\/s41467-024-46603-2<\/a>. PubMed PMID:38486040<\/a> PubMed Central PMC10940585<\/a>.<\/li>\n\n\n\n
  85. Macedo, AC, Therriault, J, Tissot, C, Fernandez-Arias, J, Ferreira, PCL, Vitali, P et al.<\/em>. Predicting functional decline in aging and Alzheimer’s disease with PET-based Braak staging. Brain Commun. 2024;6 (2):fcae043. doi: 10.1093\/braincomms\/fcae043<\/a>. PubMed PMID:38482373<\/a> PubMed Central PMC10935644<\/a>.<\/li>\n\n\n\n
  86. Therriault, J, Ashton, NJ, Pola, I, Triana-Baltzer, G, Brum, WS, Di Molfetta, G et al.<\/em>. Comparison of two plasma p-tau217 assays to detect and monitor Alzheimer’s pathology. EBioMedicine. 2024;102 :105046. doi: 10.1016\/j.ebiom.2024.105046<\/a>. PubMed PMID:38471397<\/a> PubMed Central PMC10943661<\/a>.<\/li>\n\n\n\n
  87. Lee, KKY, Chattopadhyaya, B, do Nascimento, ASF, Moquin, L, Rosa-Neto, P<\/strong>, Amilhon, B et al.<\/em>. Neonatal hypoxia impairs serotonin release and cognitive functions in adult mice. Neurobiol Dis. 2024;193 :106465. doi: 10.1016\/j.nbd.2024.106465<\/a>. PubMed PMID:38460800<\/a> .<\/li>\n\n\n\n
  88. Therriault, J, Schindler, SE, Salvad\u00f3, G, Pascoal, TA, Benedet, AL, Ashton, NJ et al.<\/em>. Biomarker-based staging of Alzheimer disease: rationale and clinical applications. Nat Rev Neurol. 2024;20 (4):232-244. doi: 10.1038\/s41582-024-00942-2<\/a>. PubMed PMID:38429551<\/a> .<\/li>\n\n\n\n
  89. Chu, M, Jiang, D, Li, D, Yan, S, Liu, L, Nan, H et al.<\/em>. Atrophy network mapping of clinical subtypes and main symptoms in frontotemporal dementia. Brain. 2024;147 (9):3048-3058. doi: 10.1093\/brain\/awae067<\/a>. PubMed PMID:38426222<\/a>PubMed Central PMC11370799<\/a>.<\/li>\n\n\n\n
  90. Soares, C, Da Ros, LU, Machado, LS, Rocha, A, Lazzarotto, G, Carello-Collar, G et al.<\/em>. The glutamatergic system in Alzheimer’s disease: a systematic review with meta-analysis. Mol Psychiatry. 2024;29 (7):2261-2273. doi: 10.1038\/s41380-024-02473-0<\/a>. PubMed PMID:38366114<\/a> .<\/li>\n\n\n\n
  91. Ferrari-Souza, JP, Brum, WS, Hauschild, LA, Da Ros, LU, Ferreira, PCL, Bellaver, B et al.<\/em>. Vascular risk burden is a key player in the early progression of Alzheimer’s disease. Neurobiol Aging. 2024;136 :88-98. doi: 10.1016\/j.neurobiolaging.2023.12.008<\/a>. PubMed PMID:38335912<\/a> PubMed Central PMC11416150<\/a>.<\/li>\n\n\n\n
  92. De Bastiani, MA, Bellaver, B, Carello-Collar, G, Zimmermann, M, Kunach, P, Lima-Filho, RAS et al.<\/em>. Cross-species comparative hippocampal transcriptomics in Alzheimer’s disease. iScience. 2024;27 (1):108671. doi: 10.1016\/j.isci.2023.108671<\/a>. PubMed PMID:38292167<\/a> PubMed Central PMC10824791<\/a>.<\/li>\n\n\n\n
  93. Linnemann, C, Wilke, C, Mengel, D, Zetterberg, H, Heller, C, Kuhle, J et al.<\/em>. NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study. J Neurol Neurosurg Psychiatry. 2024;95 (9):822-828. doi: 10.1136\/jnnp-2023-332464<\/a>. PubMed PMID:38253362<\/a> PubMed Central PMC11347244<\/a>.<\/li>\n\n\n\n
  94. Ashton, NJ, Brum, WS, Di Molfetta, G, Benedet, AL, Arslan, B, Jonaitis, E et al.<\/em>. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology. JAMA Neurol. 2024;81 (3):255-263. doi: 10.1001\/jamaneurol.2023.5319<\/a>. PubMed PMID:38252443<\/a> PubMed Central PMC10804282<\/a>.<\/li>\n\n\n\n
  95. Scala, SG, Kang, MS, Cox, SML, Rosa-Neto, P<\/strong>, Massarweh, G, Leyton, M et al.<\/em>. Mesocorticolimbic function in cocaine polydrug users: A multimodal study of drug cue reactivity and cognitive regulation. Addict Biol. 2024;29 (1):e13358. doi: 10.1111\/adb.13358<\/a>. PubMed PMID:38221806<\/a> PubMed Central PMC10898841<\/a>.<\/li>\n\n\n\n
  96. Benussi, A, Premi, E, Grassi, M, Alberici, A, Cantoni, V, Gazzina, S et al.<\/em>. Diagnostic accuracy of research criteria for prodromal frontotemporal dementia. Alzheimers Res Ther. 2024;16 (1):10. doi: 10.1186\/s13195-024-01383-1<\/a>. PubMed PMID:38216961<\/a> PubMed Central PMC10785469<\/a>.<\/li>\n\n\n\n
  97. Therriault, J, Woo, MS, Salvad\u00f3, G, Gobom, J, Karikari, TK, Janelidze, S et al.<\/em>. Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology. Mol Neurodegener. 2024;19 (1):2. doi: 10.1186\/s13024-023-00689-2<\/a>. PubMed PMID:38185677<\/a> PubMed Central PMC10773025<\/a>.<\/li>\n\n\n\n
  98. Lantero-Rodriguez, J, Montoliu-Gaya, L, Benedet, AL, Vrillon, A, Dumurgier, J, Cognat, E et al.<\/em>. CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease. Acta Neuropathol. 2024;147 (1):12. doi: 10.1007\/s00401-023-02659-w<\/a>. PubMed PMID:38184490<\/a> PubMed Central PMC10771353<\/a>.<\/li>\n\n\n\n
  99. Li, X, Naveed Iqbal Qureshi, M, Laplante, DP, Elgbeili, G, Paquin, V, Lee Jones, S et al.<\/em>. Decreased amygdala-sensorimotor connectivity mediates the association between prenatal stress and broad autism phenotype in young adults: Project Ice Storm. Stress. 2024;27 (1):2293698. doi: 10.1080\/10253890.2023.2293698<\/a>. PubMed PMID:38131654<\/a> .<\/li>\n\n\n\n
  100. Aumont, E, Bussy, A, Bedard, MA, Bezgin, G, Therriault, J, Savard, M\u00a0et al.<\/em>. Hippocampal subfield associations with memory depend on stimulus modality and retrieval mode. Brain Commun. 2023;5 (6):fcad309. doi:\u00a010.1093\/braincomms\/fcad309<\/a>. PubMed\u00a0PMID:38035364<\/a>\u00a0PubMed Central\u00a0PMC10681971<\/a>.<\/li>\n<\/ol>\n\n\n\n

    Search PubMed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

    Search PubMed<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":71,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/pages\/120"}],"collection":[{"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/comments?post=120"}],"version-history":[{"count":4,"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/pages\/120\/revisions"}],"predecessor-version":[{"id":3872,"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/pages\/120\/revisions\/3872"}],"up":[{"embeddable":true,"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/pages\/71"}],"wp:attachment":[{"href":"https:\/\/mcsa.ca\/index.php\/wp-json\/wp\/v2\/media?parent=120"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}